Multiplikator Forward P/S: Bone Biologics Corp (BBLG)
The projected P/S metric on this GURU.Markets platform chart, where the parameter value reaches , correlates with the dominance of Bone Biologics (BBLG) in the spinal regeneration niche due to patent protection. Production capacities for matrix output operate strictly according to industry standards. This strengthens its status as a biotech innovator, building physician trust by accelerating the healing of complex fractures.
Ringkesan rincian data analitis Bone Biologics Inc (BBLG)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Bone Biologics|BBLG - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Bone Biologics|BBLG - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Bone Biologics Inc|BBLG - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Bone Biologics|Rasio cepet bonebiologics.com
- rincian asil keuangan lan kelipatan valuasi:
BBLG - Penghasilan resik perusahaan|Bathi sing dikarepake Bone Biologics|BBLG - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Bone Biologics Corporation|BBLG - Pangali PEG|Pangali EV/EBITDA Bone Biologics Inc|BBLG - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Bone Biologics|BBLG - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan bonebiologics.com|BBLG - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Bone Biologics
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:BBLG (Bone Biologics Corp)
The forward P/S reflects the market value of Bone Biologics (BBLG) relative to its expected annual revenue, allowing for an assessment of investor optimism regarding future cash flows. Analyzing the issuer's forward P/S reveals how a high speculative premium offsets the lack of current regulatory approvals, leaving the business extremely vulnerable to any technological failures or changes in the cost of debt.
Karo sapa Bone Biologics saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD Inc. - Rasio rega marang pendapatan sing dikarepake|ZJYL: Multiplikator Forward P/S|VANI (Vivani Medical) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Xtant Medical Holdings, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeuroOne NMTC|Rasio rega marang prakiraan pendapatan Modular Medical (MODD)|Myomo Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S COCH (Envoy Medical, Inc.)|vivoslife.com (VVOS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|NVNO: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SINT (Sintx Technologies)|TNON: Multiplikator Forward P/S|LFWD (Lifeward Ltd.) - Rasio rega marang prakiraan pendapatan|AMIX (Autonomix Medical Inc.) - Multiplikator Forward P/S|invobioscience.com (IVF) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Axonics (AXNX)|BIOL - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|Paragon 28 Inc. - Rasio rega marang prakiraan pendapatan|INVO - Rasio rega marang prakiraan pendapatan
